Enozertinib (hemihydrate)

CAT: 0804-HY-172429A-01Size: 5 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0804-HY-172429A-01Size:5 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

Enozertinib (ORIC-114) hemihydrate is the inhibitor for EGFR that exhibits antineoplastic activity[1].

Product Name Alternative

ORIC-114 (hemihydrate)

UNSPSC

12352005

Target

EGFR

Related Pathways

JAK/STAT Signaling; Protein Tyrosine Kinase/RTK

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Purity

99.98

Smiles

C=CC(NC1=C(N2CCC(N3CCN(C4CC4)CC3)CC2)C=C(C(NC5=NC=NC(N6[C@@H](C7=CC(F)=CC(F)=C7)CCO6)=C5)=C1)OC)=O.O.[0.5]

Molecular Formula

C35H42F2N8O3.1/2H2O

Molecular Weight

669.77

References & Citations

[1]WHO-Volume38 Number4 2024

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

Phase 2

Related Products